Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,318,686
-$125,294,976 QoQ
Shares Held
138,797
-81.9% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#201
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FRED ALGER MANAGEMENT, LLC holds $736,177,545 across 12 Drug Manufacturers - General names. AZN ranks #6 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
4,907,570 | $235,268,905 | |
| 2 | BIIB |
Biogen Inc.
|
788,307 | $170,321,610 | |
| 3 | JNJ |
Johnson & Johnson
|
444,151 | $112,801,029 | |
| 4 | LLY |
ELI LILLY & Co
|
75,669 | $90,759,676 | |
| 5 | MRK |
Merck & Co., Inc.
|
487,735 | $62,673,947 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
138,797 | $26,318,686 | |
| 7 | ABBV |
AbbVie Inc.
|
67,742 | $17,046,596 | |
| 8 | AMGN |
Amgen Inc
|
14,074 | $5,096,476 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,318,686 | 138,797 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $151,613,662 | 768,754 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||